Carl Icahn’s Icahn Capital Keeps Buying $NAV

Carl Icahn’s Icahn Capital reported 9.99% activist stake in in Navistar International Corporation (NAV) on November 2nd. This is the second 13D filed by Carl Icahn for his NAV position after the second quarter. Carl Icahn focused on the call options and reported his continuous purchases from September 2nd to November 2nd. He now has 7.25 million shares in NAV, up by 2% from its previous position of 7.11 million shares on October 13th. Carl Icahn did not have any share in NAV in the second quarter, and he began to build his position after August 23rd. NAV has lost 27% in 2011. The stock is now trading at $42.36.


NAV was a popular stock loved by hedge funds in the second quarter. Thirty seven hedge funds in our list had the stock in their portfolios. Alec Litowitz and Ross Laser’s Magnetar Capital had 24.81 million shares, corresponding to a more than 30% stake in the stock. Jeffrey Altman’s Owl Creek Asset Management had 6.87 million shares, or 9.47% stake. Several famous hedge funds also had some positions in NAV. Jim Simons’ Renaissance Technologies had 437 thousand shares. Steven Cohen’s Sac Capital Advisors had 74 thousand shares, and Ken Griffin’s Citadel Investment Group had 55 thousand shares.

Carl Icahn is an American business magnate and legendary corporate raider. He began his career on Wall Street in 1961. In 2007, he founded Icahn Capital LP, which is a wholly-owned subsidiary of Icahn Enterprises L.P. Carl Icahn recently announced that he will be returning $1.76 Billion back to his investors. He will continue investing his own money. He is an excellent insider to imitate because his moves are usually bigger than an average hedge fund’s and he has to report them more promptly on 13D forms because he usually takes activist positions.

According to Yahoo! Finance, Navistar International Corporation engages in manufacturing and selling “commercial and military trucks, buses, diesel engines, recreational vehicles, and chassis”. It operates in Truck segment, Engine segment, Parts segment, and Financial Services segment. The company mainly markets its products through dealers and distributors in the United States, Canada, Mexico, Brazil, Argentina, and India.

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!